BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 37005658)

  • 41. Design strategies and application progress of therapeutic exosomes.
    Liu C; Su C
    Theranostics; 2019; 9(4):1015-1028. PubMed ID: 30867813
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exosomes in sarcoma: Prospects for clinical applications.
    Ye H; Tan L; Tu C; Min L
    Crit Rev Oncol Hematol; 2023 Jan; 181():103895. PubMed ID: 36481305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Engineering exosomes and biomaterial-assisted exosomes as therapeutic carriers for bone regeneration.
    Lu Y; Mai Z; Cui L; Zhao X
    Stem Cell Res Ther; 2023 Mar; 14(1):55. PubMed ID: 36978165
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of RGD-engineered exosomes for enhanced targeting ability and synergistic therapy toward angiogenesis.
    Wang J; Li W; Lu Z; Zhang L; Hu Y; Li Q; Du W; Feng X; Jia H; Liu BF
    Nanoscale; 2017 Oct; 9(40):15598-15605. PubMed ID: 28990632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell-free exosome-laden scaffolds for tissue repair.
    Huang J; Xiong J; Yang L; Zhang J; Sun S; Liang Y
    Nanoscale; 2021 May; 13(19):8740-8750. PubMed ID: 33969373
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exosome-based Tumor Therapy: Opportunities and Challenges.
    Li C; Hou X; Zhang P; Li J; Liu X; Wang Y; Guan Q; Zhou Y
    Curr Drug Metab; 2020; 21(5):339-351. PubMed ID: 32410558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exosomes as a Nanodelivery System: a Key to the Future of Neuromedicine?
    Aryani A; Denecke B
    Mol Neurobiol; 2016 Mar; 53(2):818-834. PubMed ID: 25502465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exosomes: Isolation, characterization, and biomedical applications.
    Alzhrani GN; Alanazi ST; Alsharif SY; Albalawi AM; Alsharif AA; Abdel-Maksoud MS; Elsherbiny N
    Cell Biol Int; 2021 Sep; 45(9):1807-1831. PubMed ID: 33913604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exosomes as therapeutics: The implications of molecular composition and exosomal heterogeneity.
    Ferguson SW; Nguyen J
    J Control Release; 2016 Apr; 228():179-190. PubMed ID: 26941033
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The potential therapeutic value and application prospect of engineered exosomes in human diseases.
    Liu G; Wu J; Chen G; Shang A
    Front Cell Dev Biol; 2022; 10():1051380. PubMed ID: 36531952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exosome therapeutics for lung regenerative medicine.
    Popowski K; Lutz H; Hu S; George A; Dinh PU; Cheng K
    J Extracell Vesicles; 2020 Jun; 9(1):1785161. PubMed ID: 32944172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations.
    Kim MS; Haney MJ; Zhao Y; Yuan D; Deygen I; Klyachko NL; Kabanov AV; Batrakova EV
    Nanomedicine; 2018 Jan; 14(1):195-204. PubMed ID: 28982587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Comprehensive Review on the Applications of Exosomes and Liposomes in Regenerative Medicine and Tissue Engineering.
    Shafiei M; Ansari MNM; Razak SIA; Khan MUA
    Polymers (Basel); 2021 Jul; 13(15):. PubMed ID: 34372132
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exosomes as nanocarriers for siRNA delivery: paradigms and challenges.
    Shahabipour F; Banach M; Sahebkar A
    Arch Med Sci; 2016 Dec; 12(6):1324-1326. PubMed ID: 27904525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Engineered Exosomes: A Promising Drug Delivery Strategy for Brain Diseases.
    Jiang Y; Wang F; Wang K; Zhong Y; Wei X; Wang Q; Zhang H
    Curr Med Chem; 2022; 29(17):3111-3124. PubMed ID: 34477508
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Post isolation modification of exosomes for nanomedicine applications.
    Hood JL
    Nanomedicine (Lond); 2016 Jul; 11(13):1745-56. PubMed ID: 27348448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exosomes as Theranostics for Lung Cancer.
    Srivastava A; Amreddy N; Razaq M; Towner R; Zhao YD; Ahmed RA; Munshi A; Ramesh R
    Adv Cancer Res; 2018; 139():1-33. PubMed ID: 29941101
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics.
    Yang D; Zhang W; Zhang H; Zhang F; Chen L; Ma L; Larcher LM; Chen S; Liu N; Zhao Q; Tran PHL; Chen C; Veedu RN; Wang T
    Theranostics; 2020; 10(8):3684-3707. PubMed ID: 32206116
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exosomes and their Application in Biomedical Field: Difficulties and Advantages.
    Rezaie J; Ajezi S; Avci ÇB; Karimipour M; Geranmayeh MH; Nourazarian A; Sokullu E; Rezabakhsh A; Rahbarghazi R
    Mol Neurobiol; 2018 Apr; 55(4):3372-3393. PubMed ID: 28497202
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exosomes as novel bio-carriers for gene and drug delivery.
    Jiang XC; Gao JQ
    Int J Pharm; 2017 Apr; 521(1-2):167-175. PubMed ID: 28216464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.